"From chemotherapy and radiation therapy to personal holistic services, Altru Cancer Center offers the best cancer treatment available."

During the past decade, Altru Cancer Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 100 clinical trials were completed, i.e. on average, 243.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 34 clinical trials were completed. i.e. 340% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Altru Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 75 trials, followed by "National Cancer Institute (NCI)" with 50 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altru Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 119 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "North Central Cancer Treatment Group" with 11 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Altru Cancer Center" are "Breast Cancer" (30 trials), "Lung Cancer" (15 trials), "Colorectal Cancer" (9 trials), "Recurrent Breast Carcinoma" (9 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (8 trials). Many other conditions were trialed in "Altru Cancer Center" in a lesser frequency.

Most popular intervention types in "Altru Cancer Center" are "Drug" (145 trials), "Other" (93 trials), "Biological" (55 trials), "Radiation" (34 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (28 trials), "placebo" (25 trials), "Paclitaxel" (17 trials) and "Bevacizumab" (14 trials). Other intervention names were less common.

The vast majority of trials in "Altru Cancer Center" are 129 trials for "All" genders, 36 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Altru Cancer Center". undefined are not yet recruiting, 18 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Altru Cancer Center, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Altru Cancer Center, 10 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".